A Phase II Study of RAD001 (Everolimus) in Patients With Fluoropyrimidine and Platinum-Refractory Advanced Gastric Cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2013
At a glance
- Drugs Everolimus (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 02 Aug 2012 Additional trial identifier (AMC0702) added as reported by ClinicalTrials.gov record.
- 28 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.